Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Blood Donations
Company introduces enhanced red cell collection technology
September 5th, 2004
Haemonetics Corp. introduced an enhancement to its leukocytes-reduced red cell collection technology that, according to the company, triples the time within which donated blood can be filtered to remove leukocytes. Donor leukocytes can cause transfusion complications in transfusion recipients. Previous technology required that blood be filtered within 24 hours of donation. Now, blood can be filtered for up to 3 days after donation. The U.S. Food and Drug Administration cleared this newest protocol in August 2004. Dr. Mark Popovsky, Haemonetics' vice president and corporate medical director, said, "In response to customers' needs,...
Source: Medical Letter on the CDC & FDA (2004-09-05)
|
